Hormones therapy on the heart health of transgender men and women has the subject of several studies publish within the last year. But medical experts and researchers aren’t ready to sound the alarm just yet. They have to recognize that hormones can be lifesaving therapy for trans people, said Dr. Richard Greene. The answer is…
Endocrine Disruptors; Phthalates, one of the most common endocrine disruptors, are commonly used by industry in many plastic products toys, clothing, baby bottles or even medical equipment as well as in cosmetics. If guidelines are beginning to be imposed to limit their use, their toxic effect on the endocrine system is worrying. Common endocrine disruptors…
Trans generational bisphenol A (BPA) exposure may contribute to autism, according to a mouse study published in the Endocrine Society’s journal Endocrinology. Endocrine disrupting chemicals (EDCs) are chemicals or mixtures of chemicals that interfere with the way the body’s hormones work. Bisphenol A has document trans generational effects on social behavior, heart, and reproductive functions,…
Type 1 Diabetes; Study co-led by Dr. Nelly Mauras at Nemours Children’s Health System in Jacksonville, Florida found that children with type 1 diabetes (T1D) have slower growth in brain areas associated with mild cognitive deficits compared to children without T1D. The study, presented today at the American Diabetes Association’s (ADA’s) 79th Scientific Sessions, found…
MicroRNA; Researchers know that exosomes, tiny nano particles released from fat cells, travel through the bloodstream and body, regulating a variety of processes, from growth and development to metabolism. The exosomes are important in lean, healthy individuals in maintaining homeostasis; but when fat gets ‘sick’ the most common reason for this is too much weight…
Thyroid hormone, Although most victims survive the 735,000 heart attacks that occur annually in the U.S., their heart tissue is often irreparably damaged unlike many other cells in the body, once injure, heart cells cannot regenerate. According to a new UC San Francisco study. The issue may date back to our earliest mammalian ancestors; which…
Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study present by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute’s Lank Center for Genitourinary Oncology; so during the American Society of Clinical Oncology (ASCO) Annual Meeting. Interim analysis of the ANZUP-led international randomize; so…
The Despite potential for prolonging survival with treatment, so one third of patients with metastatic pancreatic cancer do not see a medical oncologist, and even more do not receive cancer direct treatment, find new research published in CMAJ (Canadian Medical Association Journal). Pancreatic cancer begins in the tissues of your pancreas an organ in your abdomen…
From 1973 to 2013, there was an increase in the incidence rates of pediatric thyroid cancer, with marked increases from 2006 to 2013, according to a study publish online May 23 in JAMA Otolaryngology-Head & Neck Surgery. Z. Jason Qian, M.D., from the Stanford University School of Medicine in California, and colleagues analyze trends in…
Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care. Prashanth Patel, M.B.B.S., from the University Hospitals of Leicester NHS Trust in the United Kingdom, and colleagues use liquid chromatography-tandem mass spectrometry analysis to measure nonadherence to…
Obesity is a growing public health crisis, bringing with it many serious risk factors, including cardiovascular disease and type 2 diabetes. As the number of people who are either overweight or obese now out numbers those with a healthy body weight by a ratio of two to one, researchers face an urgent need to better…
Estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative patients account for 70% of early-stage invasive breast cancer. In current clinical practice, these patients receive either endocrine therapy or chemo-endocrine therapy as adjuvant treatment. The 2017 St. Gallen consensus meeting recommend that adjuvant treatment for ER-positive; also HER2-negative breast cancer should be escalate…